Tags

Type your tag names separated by a space and hit enter

Mefloquine-induced pneumonitis.
J Travel Med. 2006 May-Jun; 13(3):172-4.JT

Abstract

Mefloquine is indicated as oral treatment and as prophylaxis for malaria in areas where chloroquine-resistant malaria is present. Gastrointestinal and neuropsychiatric side effects of mefloquine are well known. More severe neuropsychiatric disorders such as psychosis, depression, hallucinations, and seizures are also reported in the literature. We are reporting a case of drug-induced pneumonia due to mefloquine. This diagnosis was confirmed 4 months after the adverse event, after restarting the same malaria prophylaxis, which could be considered as an unintentional provocation test. This is the third case report in the literature of acute lung injury caused by mefloquine.

Authors+Show Affiliations

Department of Internal Medicine, University Hospital Gasthuisberg, Leuven, Belgium.No affiliation info availableNo affiliation info available

Pub Type(s)

Case Reports
Journal Article

Language

eng

PubMed ID

16706949

Citation

Soentjens, Patrick, et al. "Mefloquine-induced Pneumonitis." Journal of Travel Medicine, vol. 13, no. 3, 2006, pp. 172-4.
Soentjens P, Delanote M, Van Gompel A. Mefloquine-induced pneumonitis. J Travel Med. 2006;13(3):172-4.
Soentjens, P., Delanote, M., & Van Gompel, A. (2006). Mefloquine-induced pneumonitis. Journal of Travel Medicine, 13(3), 172-4.
Soentjens P, Delanote M, Van Gompel A. Mefloquine-induced Pneumonitis. J Travel Med. 2006 May-Jun;13(3):172-4. PubMed PMID: 16706949.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Mefloquine-induced pneumonitis. AU - Soentjens,Patrick, AU - Delanote,Marc, AU - Van Gompel,Alfons, PY - 2006/5/19/pubmed PY - 2006/8/3/medline PY - 2006/5/19/entrez SP - 172 EP - 4 JF - Journal of travel medicine JO - J Travel Med VL - 13 IS - 3 N2 - Mefloquine is indicated as oral treatment and as prophylaxis for malaria in areas where chloroquine-resistant malaria is present. Gastrointestinal and neuropsychiatric side effects of mefloquine are well known. More severe neuropsychiatric disorders such as psychosis, depression, hallucinations, and seizures are also reported in the literature. We are reporting a case of drug-induced pneumonia due to mefloquine. This diagnosis was confirmed 4 months after the adverse event, after restarting the same malaria prophylaxis, which could be considered as an unintentional provocation test. This is the third case report in the literature of acute lung injury caused by mefloquine. SN - 1195-1982 UR - https://www.unboundmedicine.com/medline/citation/16706949/Mefloquine_induced_pneumonitis_ L2 - https://academic.oup.com/jtm/article-lookup/doi/10.1111/j.1708-8305.2006.00037.x DB - PRIME DP - Unbound Medicine ER -